AndrewSharabiMD
Radiation Oncology • La Jolla, CAAssociate Professor and Director of the Center for Precision Radiation Medicine
Dr. Sharabi is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Connect with other colleagues in the same hospital or clinic
- Search all U.S. specialist profiles and refer a patient
- Read the latest clinical news and earn CME/CEU credits
Office
3855 Health Sciences Dr
La Jolla, CA 92093- Is this information wrong?
Education & Training
Johns Hopkins UniversityResidency, Radiation Oncology, 2011 - 2015
Methodist Hospital (Houston)Internship, Transitional Year, 2010 - 2011
Baylor College of MedicineClass of 2010
Certifications & Licensure
CA State Medical License 2015 - 2024- American Board of Radiology Radiation Oncology
Clinical Trials
- Immunologic Responses in HPV-Associated Carcinoma for Patients Receiving Chemoradiation Start of enrollment: 2015 Jan 07
- Checkpoint Blockade Immunotherapy Combined With Stereotactic Body Radiation in Advanced Metastatic Disease Start of enrollment: 2016 May 03
- Stereotactic Body Radiation Therapy (SBRT) Combined With Avelumab (Anti-PD-L1) for Management of Early Stage Non-Small Cell Lung Cancer (NSCLC) Start of enrollment: 2017 Oct 26
Publications & Presentations
PubMed
- Computational and AI-driven 3D structural analysis of human papillomavirus (HPV) oncoproteins E5, E6, and E7 reveal significant divergence of HPV E5 between low-risk a...Jones, R., Miyauchi, S., Roy, S., Boutros, N., Venuti, A., Mayadev, J., Mell, L., Califano, J., Sharabi, A.> ;Virology. 2024 Feb 1
- 11 citationsHuman papillomavirus E5 suppresses immunity via inhibition of the immunoproteasome and STING pathway.Sayuri Miyauchi, Sangwoo S Kim, Riley N Jones, Lin Zhang, Kripa Guram, Sonia Sharma, Stephen P Schoenberger, Ezra E W Cohen, Joseph A Califano, Andrew B Sharabi> ;Cell Reports. 2023 May 30
- 1 citationsTargeting macrophage Syk enhances responses to immune checkpoint blockade and radiotherapy in high-risk neuroblastoma.Deepak Rohila, In Hwan Park, Timothy V Pham, Riley Jones, Elisabette Tapia, Kevin X Liu, Pablo Tamayo, Alice Yu, Andrew B Sharabi, Shweta Joshi> ;Frontiers in Immunology. 2023 Jan 1
- Join now to see all
Press Mentions
Toragen, Inc. Announces Appointment of Dr. Sandra Coufal, M.D. As CEOFebruary 9th, 2022- Toragen, Inc. Announces Appointment of Dr. Sandra Coufal, M.D. As CEOFebruary 9th, 2022
- Shop TalkJanuary 5th, 2018
- Join now to see all
Hospital Affiliations
UC San Diego Medical Center - HillcrestSan Diego, California
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
